Device: Desktop
|
Follow the General Meeting of May 27, 2025 live (in French).
Register now!
  • Home
    Innovation
    Mission
    Latest News
  • Meet Us
    Management Team
    Corporate Team
    Key R&D Team
    Board of Directors
    Scientific Advisory Board
  • Science
    Molecular Target
    Mechanism of Action
    Aelis Farma's Targets
  • Pipeline
    AEF0117
    AEF0217
    New CB1-SSi
  • Partners
  • News
  • Contact
  • Investors
  • Home

  • Meet Us

  • Science

  • Pipeline

  • Partners

  • News

  • Contact

  • Investors

All articles
Mar 27, 2025

Final Phase 2B Results with AEF0117 in Cannabis Use Disorder (CUD)


Press release to announce the Final Phase 2B Results with AEF0117 in Cannabis Use Disorder (CUD) published on March 26, 2025

Webinar replay held on March 27, 2025


Aelis Farma
Aelis Farma Headquarter
1 rue Lafaurie de Monbadon
33 000 Bordeaux - France
Aelis Farma Lab Facilities
IECB
2 rue Robert Escarpit
33607 Pessac - France
Tel: +33 (0)5 54 54 23 27
contact@aelisfarma.com
This website is co-financed by
the European Union and the New Aquitaine Region.
L’Europe s’engage en Nouvelle Aquitaine avec
les Fonds Européens de Développement Régional.

Aelis Farma - Copyright © 2025
- web design by Kaarma Digital.
Contact | Imprint |